MLchartDataset catalogue

Copiktra

Term · Oncology and biomedicine · MLC-T-ONC-002053

A drug used to treat adults with chronic lymphocytic leukemia or small lymphocytic lymphoma that came back or did not get better after treatment with at least two other therapies. It is also being studied in the treatment of other types of cancer. Copiktra blocks certain proteins, which may help keep cancer cells from growing and may kill them. It is a type of kinase inhibitor. Also called duvelisib.

Table 1. Record
IdentifierMLC-T-ONC-002053
FieldOncology and biomedicine
Synonymsduvelisib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-002053",
  "term": "Copiktra",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with chronic lymphocytic leukemia or small lymphocytic lymphoma that came back or did not get better after treatment with at least two other therapies. It is also being studied in the treatment of other types of cancer. Copiktra blocks certain proteins, which may help keep cancer cells from growing and may kill them. It is a type of kinase inhibitor. Also called duvelisib.",
  "synonyms": [
    "duvelisib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/copiktra/"
}

Record 5,273 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.